Additionally, IDH1, R132H, and PPM1D mutant gliomas have been shown to selectively rely on NAD salvage pathways, suggesting these sub-populations of tumors may benefit from NAMPT inhibition (37–39). Here, IDH1 is linked to central nervous system cancer.